| 1 |
28081207 | Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNβ. | 2017 |
1 |
| 2 |
28293479 | MxA mRNA decrease preceding NAb detection in IFNβ-treated MS patients. | 2017 Mar |
2 |
| 3 |
24444338 | Anti-interferon beta antibody titers strongly correlate between two bioassays and in vivo biomarker expression, and indicates that a titer of 150 TRU/mL is a biologically functional cut-point. | 2014 Jul |
3 |
| 4 |
25450683 | Anti-interferon-α neutralizing antibody induced telaprevir resistance under the interferon-α plus telaprevir treatment in vitro. | 2014 Nov 21 |
1 |
| 5 |
25877635 | Preserved in vivo response to interferon-alpha in multiple sclerosis patients with neutralising antibodies against interferon-beta (REPAIR study). | 2013 Apr |
1 |
| 6 |
21685230 | Incorporation of an interferon-β neutralizing antibody assay into routine clinical practice. | 2011 Nov |
5 |
| 7 |
19028832 | Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis. | 2009 Mar |
1 |
| 8 |
19558503 | Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation. | 2009 Dec |
2 |
| 9 |
19884577 | Effect of neutralizing antibodies on biomarker responses to interferon beta: the INSIGHT study. | 2009 Nov 3 |
1 |
| 10 |
18081914 | MxA protein assay for optimal monitoring of IFN-beta bioactivity in the treatment of MS patients. | 2008 Jul |
1 |